Home・Stock List・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Closed

1.04 -1.89

Buy Sell

Overview

Share price change

24h

Current

Min

1.04

Max

1.05

Key metrics
By Trading Economics
Income	3.5M -20M
EPS	-0.32
Employees	49
EBITDA	8.6M -20M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+156.73% upside

Dividends
By Acuity
Next Earnings	5 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-7.4M 67M
Previous open	2.93
Previous close	1.04

Pliant Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

1 Aug 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading lower, reflecting a cumulative decline since Friday. The asset is approximately 2.53% below its 20-day moving average.

1 Aug 2026, 23:01 UTC

The Nikkei 225 Index is trading lower during after-market hours, reflecting a decline from earlier highs and remaining near the lower end of its one-month range.

1 Aug 2026, 20:01 UTC

Oil (Brent) is trading higher in after-market hours, reflecting strong momentum and remaining above its 20-day moving average. No specific news was identified.

1 Aug 2026, 20:01 UTC

Correlated Moves

Silver is trading lower in after-market hours, reflecting weakness since Friday's close. The price is near the lower end of its one-month range.

1 Aug 2026, 20:01 UTC

The DAX 30 Index is trading lower in after-market hours, reversing earlier gains and closing below Friday's level. No specific news was identified.

1 Aug 2026, 20:01 UTC

Correlated Moves

Gold prices are lower during after-market hours, reflecting unusual price action near the lower end of its one-month range. Silver also declined in tandem.

1 Aug 2026, 19:11 UTC

Correlated Moves

Avalanche is trading lower during Saturday's session amid a broader cryptocurrency market downturn, with Bitcoin also declining and the asset below its 20-day moving average.

1 Aug 2026, 19:01 UTC

News

Correlated Moves

Ethereum is trading lower, reflecting a broader decline in correlated assets. It remains below its 20-day moving average amid routine market fluctuations.

1 Aug 2026, 18:51 UTC

Cardano is trading higher during Saturday's session, reflecting a cumulative gain since Friday. The asset remains above its 20-day moving average.

1 Aug 2026, 18:41 UTC

Correlated Moves

Ethereum is trading lower today, influenced by declines in Bitcoin. The asset remains near the upper end of its one-month range.

1 Aug 2026, 18:01 UTC

The Nasdaq 100 Index is lower during after-market hours, declining since Friday's close and trading near the lower end of its one-month range.

1 Aug 2026, 11:52 UTC

Fed Chair Kevin Warsh's Upcoming Speech Sparks Market Speculation on Interest Rate Changes Amid Rising Inflation Concerns.

1 Aug 2026, 11:52 UTC

U.S. Nonfarm Productivity Expected to Rise 0.7% in Q2 2026 Amid Mixed Economic Signals

1 Aug 2026, 11:52 UTC

U.S. Unit Labour Costs Set to Rise 2.7% Amid Strong Wage Growth, Heightening Inflation Concerns Ahead of Federal Reserve Policy Decisions

1 Aug 2026, 11:51 UTC

Swiss markets closed for National Day; Bitcoin and Ethereum see slight gains, while concerns grow over U.S. stock market reliance on AI-driven stocks and potential Japanese Yen interventions.

1 Aug 2026, 11:51 UTC

"Bitcoin and Ethereum see gains amid speculation, while U.S. Dollar dips as traders eye key economic data and potential Fed policy shifts."

1 Aug 2026, 11:51 UTC

Bitcoin and Ethereum see modest gains amid economic uncertainties, while U.S. stock market concentration raises investor concerns and key labor data looms ahead.

1 Aug 2026, 11:51 UTC

Swiss markets closed for National Day; U.S. stocks rally amid inflation concerns and upcoming key labor data.

1 Aug 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026 Expected to Show Continued Easing Amid Global Trends.

1 Aug 2026, 11:41 UTC

U.S. Mortgage Rates Hit One-Year High at 6.66%, Raising Concerns Over Homebuying Demand Ahead of MBA Release on August 5

1 Aug 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026: Market Anticipates Impact on Economic Policy Amid Mixed Sentiment and External Risks.

1 Aug 2026, 11:31 UTC

U.S. Exports Data Release on August 4, 2026, Sparks Caution Amid Economic Slowdown and Global Trade Tensions

1 Aug 2026, 11:31 UTC

U.S. Trade Deficit Expected to Widen to -$73 Billion Amid Rising Imports and Geopolitical Tensions

1 Aug 2026, 11:22 UTC

U.S. Imports Data Release on August 4 Expected to Show Continued Growth Amid Tariff Distortions and Global Trade Dynamics

1 Aug 2026, 11:22 UTC

Canada's Balance of Trade expected to show C$3.0 billion surplus amid mixed economic sentiment and external challenges on August 4, 2026.

1 Aug 2026, 11:22 UTC

Market anticipates 75K job increase in upcoming ADP Employment Change report amid mixed economic signals and cautious optimism.

1 Aug 2026, 11:02 UTC

Japan's Upcoming Household Spending Report Signals Consumer Caution Amid Mixed Economic Indicators and Retail Disappointment.

1 Aug 2026, 11:02 UTC

Japan's Household Spending Expected to Rise 0.9% Amid Inflation Concerns and Yen Volatility Ahead of August Release

1 Aug 2026, 10:51 UTC

Brazil's Central Bank Faces Pressure on SELIC Rate Decision Amid Inflation and Economic Stability Concerns Ahead of August 5th Announcement.

1 Aug 2026, 10:51 UTC

Mexican Consumer Confidence Index Set for Release Amid Cautious Optimism and Mixed Economic Sentiment on August 4, 2026.

Peer Comparison

Price change

Pliant Therapeutics Inc Forecast

Price Target

By TipRanks

156.73% upside

12 Months Forecast

Average 2.67 USD 156.73%

High 3 USD

Low 2 USD

Based on 5 Wall Street analysts offering 12 month price targets forPliant Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to Pliant Therapeutics Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.